Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19
Here, the authors report results from a Phase 1 trial with an AS03-adjuvanted, plant-based virus-like particle displaying the spike protein of the ancestral SARS-CoV-2. Six months post-second dose, they observe good neutralizing antibody titers and T cell responses to ancestral virus and variants of...
Full description
Bibliographic Details
Main Authors: |
Philipe Gobeil,
Stéphane Pillet,
Iohann Boulay,
Nathalie Charland,
Aurélien Lorin,
Matthew P. Cheng,
Donald C. Vinh,
Philippe Boutet,
Robbert Van Der Most,
François Roman,
Maria Angeles Ceregido,
Nathalie Landry,
Marc-André D’Aoust,
Brian J. Ward |
Format: | Article
|
Language: | English |
Published: |
Nature Portfolio
2022-11-01
|
Series: | Nature Communications
|
Online Access: | https://doi.org/10.1038/s41467-022-34728-1
|